Westchester County Biosciences Accelerator Announces Second Cohort.
Westchester County Biosciences Accelerator, WCBA announced the second cohort of emerging biosciences ventures invited to participate in the annual program.
Twelve ventures will participate in the 6 month-long program that features entrepreneurship education, coaching and mentoring, to develop fundable business plans and expand the Biosciences community in Westchester. Ventures are supported by an experienced entrepreneur coach and receive customized business networking introductions to business professionals to help advance their early stage ventures.
The 2021 WCBA cohort participants and ventures include:
- Antonio Frasca (Columbia): AGEless a modification of medical device biomaterials conferring resistance to glycation & associated degeneration.
- Chandra Karunakaran (Albert Einstein College of Medicine) an ultrasound-based cancer therapy device, which primes patients’ immune systems to identify and kill the primary and metastatic tumor, improving patient outcomes.
- Cyril Eleftheriou (Cornell/ Burke Neurological Institute): an artificial dopaminergic neuron for treating light-adaptation deficits in the retinas of patients with dystrophic retinal conditions, including night-blindness.
- David Fung (New York R&D Center for Translational Medicine and Therapeutics, Inc./BioInc@NYMC) a novel microRNA-based therapeutic for tendinopathy uniquely positioned in the market to offer mitigation of disease progression while also providing pain relief.
- Eugene Dinescu (SUNY Downstate Medical) a preclinical-stage vascular therapeutics company with the world’s first peptide to directly treat neointimal disease and atherosclerosis.
- Eugene Major (Columbia) a drug delivery platform that hunts down glioblastoma (GBM) tumor cells and delivers anti-tumor drugs.
- Irina Tanenbaum (NYU Stern) a light system designed to help rejuvenate brain health and improve mental acuity.
- Kistein Monkhouse (Long Island University): a B2C digital health startup helping chronically ill underserved patients document their problems to address mistrust among underrepresented people and healthcare professionals.
- Mason Lucich (University of Houston): a personal, portable biomedicine cooler to better protect biomedicines than a refrigerator, whether at home, traveling, or preparing for a natural disaster.
- Regina Druz (Cornell): AI and behavioral economics to drive a sustainable lifestyle change to lower costs and improve outcomes in patients with non-communicable chronic diseases (NCD), starting with diabetes.
- Victor Bustos (The Rockefeller University) an accessible, accurate and affordable blood test for the diagnosis of Alzheimer's disease.
- Will Alston (Columbia) a care companion for chronic disease patients which supports symptom monitoring with clinically validated PROs, medication tracking, and patient education.
Graduating in June, 2020, WCBA alums have achieved important milestones including Farzenah Ahmadi, Laronix, starting clinical trials for their bionic voice box after closing an angel round matched by the Australian government; Bina Basinath and Jacob Nye, Colon.ai, funded by Health Wildcatters in Dallas; and Parsa Mirhaji Cognome implementing AI analytics software at Montefiore to develop the hospital’s COVID treatment protocol.
For more information on these ventures and their successes, visit www.wcbaccelerator.com/
No comments:
Post a Comment